Lung Cancer Prognosis Market
Report code - SRHL127 | Published On : NA | Status: Upcoming

Opportunities and gaps in The Global Lung Cancer Prognosis Market by Epidemiology, By Treatment Algorithm in Different Regions, By Procedures (Thoracotomy (Lobectomy, Pneumonectomy, and Segmentectomy), Minimally Invasive), By Device (Surgical (Clamps, Forceps, Retractors, Others and by Monitoring Devices - Camera, Trocar and Endoscopic Instrument) and by Region (North America, Western Europe, Asia-Pacific, Latin America, Rest of the World)

This report, from Stratview Research, studies the global lung cancer prognosis over the trend period of 2014 to 2017 and forecast period of 2018 to 2025. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.

The Burning Questions This Report Will Answer:

  1. Over 1.5 million people worldwide die from lung cancer per year; why does the disease still has an extremely poor prognosis with all the modern technology?
  2. What are the options available for accurate prediction of lung cancer?
  3. Which market is more lucrative pharma, diagnostics or surgery?
  4. Which technologies are available currently and how will the future technologies disrupt the market?

The Lung Cancer Prognosis Market: Highlights

Oncologists are increasingly prescribing targeted drugs for tumour with specific molecular aberrations such as inhibitors of changed or amplified proteins such as EGFR or ALK in lung cancer. Among other trends, increased use of antibody (replacing) than chemotherapy, is revolutionizing the treatment of lung cancer. These paradigm shifts in treatment is changing the overall way Lung cancer is treated in the developed markets.

The study identifies the shift behind shift of lung cancer surgery in elderly patients and female patients, and a decrease in the proportion of patients requiring extensive pulmonary resection. Stages of lung cancer can help a doctor identify the best course of treatment, hence it is important to study the market from diagnostics and surgical procedures used to treat this condition. There are several tests to detect the stage and spread of the condition including biopsy, Imaging scans (PET, CT), Lung Function Test (Spirometry). The study gives insight on the population that requires surgery and looks at the population which are treated with medicines, depending on the metastasis.

Tyrosine-kinase inhibitors (TKIs) are gradually becoming the most popular option for lung cancer treatment in China. While in the developed markets such as the USA, cancer is no longer a single tumour type diagnosis but is defined by a combination of factors, including histology and biomarker status. The variation in treatment and requirement of surgery or just medication impacts all the stakeholders in the market who are attached as diagnostic equipment, surgical equipment, pharmaceutical or any support services, across the globe.

Research Methodology

Our reports offer high-quality insights and are the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data. About 10 detailed primary interviews with the market players across the value chain in all four regions and industry experts have been executed to obtain both the qualitative and quantitative insights.

Report Features

This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:

  • Market structure: Overview, industry life cycle analysis, supply chain analysis
  • Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
  • Market trend and forecast analysis
  • Market segment trend and forecast
  • Competitive landscape and dynamics: Market share, Product portfolio, New product launches, etc.
  • Attractive market segments and associated growth opportunities
  • Emerging trends
  • Strategic growth opportunities for the existing and new players
  • Key success factors 
  • Future outlook

The Global Lung Cancer Prognosis Market is segmented into the following categories: 

By Treatment Algorithm

  • APAC
  • North America
  • Western Europe
  • Rest of The World

By Procedures

  • Thoracotomy (Lobectomy, Pneumonectomy, Segmentectomy)
  • Minimally Invasive

By Device

  • Surgical (Clamps, Forceps, Retractors, Others)
  • Monitoring Devices (Camera, Trocar and Endoscopic Instrument)

By End-User

  • Public Hospitals
  • Private Hospitals

By Region

  • North America (Country Analysis: the USA, Canada)
  • Western Europe (Country Analysis: Germany, France, the UK)
  • Asia-Pacific (Country Analysis: China, Japan, India, and Rest of Asia-Pacific)
  • Latin America (Country Analysis: Brazil, Argentina, Mexico, and Others)
  • Rest of the World (Sub-Region Analysis: The Middle East, Africa, Rest of Europe and Others) 

Report Customization Options

With this detailed report, Stratview Research offers one of the following free customization options to our first-time clients:

Company Profiling

  • SWOT analysis of key players (up to 3 players)
  • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

Custom Research: Stratview research offers custom research services across sectors. In the case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at

By clicking Submit button you accept our terms and conditions

Related Reports

Looking for Customized Report?

By clicking Submit button you accept our terms and conditions

Our Clients

Call Us : +1-313-307-4176